These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24582632)

  • 41. Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.
    Blanton L; Dugan VG; Abd Elal AI; Alabi N; Barnes J; Brammer L; Budd AP; Burns E; Cummings CN; Garg S; Garten R; Gubareva L; Kniss K; Kramer N; O'Halloran A; Reed C; Rolfes M; Sessions W; Taylor C; Xu X; Fry AM; Wentworth DE; Katz J; Jernigan D
    MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(6):125-134. PubMed ID: 30763296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
    Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update: Influenza Activity--United States and Worldwide, May 24-September 5, 2015.
    Blanton L; Kniss K; Smith S; Mustaquim D; Steffens C; Flannery B; Fry AM; Bresee J; Wallis T; Garten R; Xu X; Elal AI; Gubareva L; Wentworth DE; Burns E; Katz J; Jernigan D; Brammer L
    MMWR Morb Mortal Wkly Rep; 2015 Sep; 64(36):1011-6. PubMed ID: 26390411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012.
    Sullivan SG; Kelly H
    Euro Surveill; 2013 Oct; 18(41):20605. PubMed ID: 24135124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study on the antigenicity and HA1 gene characteristics of influenza A viruses during 2004-2008 year in China].
    Zhang Y; Zhao X; Huang WJ; Guo JF; Wei HJ; Cheng YH; Li XW; Li XY; Guo YJ; Shu YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):405-8. PubMed ID: 20718339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recommended composition of influenza virus vaccines for use in the 2016 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2015 Oct; 90(41):545-59. PubMed ID: 26454888
    [No Abstract]   [Full Text] [Related]  

  • 48. Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18.
    Melidou A; Broberg E;
    Vaccine; 2017 Sep; 35(37):4828-4835. PubMed ID: 28780977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improving the representativeness of influenza viruses shared within the WHO Global Influenza Surveillance and Response System.
    Pereyaslov D; Zemtsova G; Gruessner C; Daniels RS; McCauley JW; Brown CS
    Influenza Other Respir Viruses; 2016 Mar; 10(2):68-75. PubMed ID: 26589132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season.
    López-Labrador FX; Natividad-Sancho A; Pisareva M; Komissarov A; Salvatierra K; Fadeev A; Moya A; Grudinin M; Díez-Domingo J; Afanasieva O; Konovalova N; Sominina A; Puig-Barberà J
    J Clin Virol; 2016 Nov; 84():32-38. PubMed ID: 27690141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009/10 influenza pandemic.
    Okoli GN; Racovitan F; Abdulwahid T; Righolt CH; Mahmud SM
    Vaccine; 2021 Feb; 39(8):1225-1240. PubMed ID: 33494964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J;
    Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrating influenza antigenic dynamics with molecular evolution.
    Bedford T; Suchard MA; Lemey P; Dudas G; Gregory V; Hay AJ; McCauley JW; Russell CA; Smith DJ; Rambaut A
    Elife; 2014; 3():e01914. PubMed ID: 24497547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seasonal trivalent influenza vaccine for 2010-2011.
    Med Lett Drugs Ther; 2010 Oct; 52(1348):77-9. PubMed ID: 20885341
    [No Abstract]   [Full Text] [Related]  

  • 55. Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine.
    Epperson S; Davis CT; Brammer L; Abd Elal AI; Ajayi N; Barnes J; Budd AP; Burns E; Daly P; Dugan VG; Fry AM; Jang Y; Johnson SJ; Kniss K; Kondor R; Grohskopf LA; Gubareva L; Merced-Morales A; Sessions W; Stevens J; Wentworth DE; Xu X; Jernigan D
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(40):880-884. PubMed ID: 31600182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
    Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
    MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012-2013 in Beijing, China.
    Fang Q; Gao Y; Chen M; Guo X; Yang X; Yang X; Wei L
    Infect Genet Evol; 2014 Aug; 26():228-40. PubMed ID: 24911284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Quadrivalent influenza vaccine: What is changed and what are the benefits?].
    Mosnier A; Launay O; Martinez L; Gavazzi G; Josset L; Crepey P; Hannoun C; Weil-Olivier C; Gaillat J
    Presse Med; 2018 Oct; 47(10):842-853. PubMed ID: 30219205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.
    Al Khatib HA; Al Thani AA; Gallouzi I; Yassine HM
    BMC Infect Dis; 2019 Apr; 19(1):314. PubMed ID: 30971204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The rationale for quadrivalent influenza vaccines.
    Ambrose CS; Levin MJ
    Hum Vaccin Immunother; 2012 Jan; 8(1):81-8. PubMed ID: 22252006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.